Synthaverse (WAR:SVE) E10: zł-0.16 (As of Mar. 2026)


WAR:SVE Synthaverse SA WAR:SVE
55 GF Score
Price zł3.00
GF Value zł3.04
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Synthaverse E10?

Synthaverse WAR:SVE +12.99% 55 E10 is zł-0.16 as of Mar. 2026. GuruFocus rates WAR:SVE with a GF Score™ of 55/100 and a GF Value™ of zł3.04 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Synthaverse's adjusted earnings per share data for the three months ended in Mar. 2026 was zł-0.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is zł-0.16 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 15.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Synthaverse was 15.70% per year. The lowest was -1.40% per year. And the median was 7.15% per year.

As of today (2026-06-30), Synthaverse's current stock price is zł3.00. Synthaverse's E10 for the quarter that ended in Mar. 2026 was zł-0.16. Synthaverse's Shiller PE Ratio of today is .


Synthaverse  (WAR:SVE) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Synthaverse E10 Related Terms


Synthaverse E10 Historical Data

* Premium members only.

The historical data trend for Synthaverse's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synthaverse E10 Chart

Synthaverse Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.24 -0.25 -0.27 -0.25 -0.15

Synthaverse Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.25 -0.26 -0.26 -0.15 -0.16

WAR:SVE vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Synthaverse's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthaverse Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synthaverse's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Synthaverse's Shiller PE Ratio falls into.


WAR:SVE
55GF Score
Synthaverse SA WAR:SVE
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synthaverse E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Synthaverse's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.05/158.3232*158.3232
=-0.050

Current CPI (Mar. 2026) = 158.3232.

Synthaverse Quarterly Data

per share eps CPI Adj_EPS
201606 -0.230 99.552 -0.366
201609 -0.087 99.064 -0.139
201612 -0.240 100.366 -0.379
201703 -0.020 101.018 -0.031
201706 -0.250 101.180 -0.391
201709 0.001 101.343 0.002
201712 0.214 102.564 0.330
201803 -0.010 102.564 -0.015
201806 -0.010 103.378 -0.015
201809 -0.010 103.378 -0.015
201812 -0.510 103.785 -0.778
201903 0.003 104.274 0.005
201906 0.007 105.983 0.010
201909 0.006 105.983 0.009
201912 0.020 107.123 0.030
202003 0.020 109.076 0.029
202006 -0.010 109.402 -0.014
202009 0.002 109.320 0.003
202012 0.060 109.565 0.087
202103 -0.020 112.658 -0.028
202106 0.050 113.960 0.069
202109 -0.009 115.588 -0.012
202112 0.050 119.088 0.066
202203 -0.010 125.031 -0.013
202206 0.040 131.705 0.048
202209 0.024 135.531 0.028
202212 0.040 139.113 0.046
202303 0.010 145.950 0.011
202306 0.040 147.009 0.043
202309 -0.034 146.113 -0.037
202312 0.055 147.741 0.059
202403 -0.010 149.044 -0.011
202406 0.020 150.997 0.021
202409 -0.006 153.439 -0.006
202412 0.100 154.660 0.102
202503 -0.010 157.021 -0.010
202506 -0.060 157.509 -0.060
202509 -0.109 157.998 -0.109
202512 -0.080 158.323 -0.080
202603 -0.050 158.323 -0.050

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of zł-0.16 mean?
Synthaverse (WAR:SVE) has a E10 of zł-0.16 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Synthaverse and its competitors.
Is Synthaverse's E10 too high?
Synthaverse's current E10 is zł-0.16. Overall, Synthaverse has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Synthaverse's E10 compare to VRTX and REGN?
Synthaverse's E10 of zł-0.16 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Synthaverse and its competitors. Synthaverse's current E10 is zł-0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synthaverse stock overvalued right now?
Based on GuruFocus' analysis, Synthaverse (WAR:SVE) is currently considered Fairly Valued. The stock's GF Value™ is zł3.04, compared to a current price of zł3.00 — trading 1.3% below its estimated fair value. The current E10 is zł-0.16. Synthaverse's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Synthaverse (WAR:SVE), the current E10 is zł-0.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synthaverse (WAR:SVE) Overvalued in 2026?

Based on GuruFocus' analysis, Synthaverse stock appears to be undervalued. The current stock price of zł3.00 is trading 1.3% below its estimated GF Value™ of zł3.04. GuruFocus considers Synthaverse to be Fairly Valued.

Key valuation signals for WAR:SVE:

  • E10: zł-0.16
  • GF Value™: zł3.04 vs. price of zł3.00 (1.3% below fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the WAR:SVE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Synthaverse Business Description

Other Exchanges 6NQ:Germany
Address 10, Uniwersytecka street, Lublin, POL, 20-029
Synthaverse SA is a global pharmaceutical company. Its goal is to provide the best, innovative and unique solutions for medicine. Its work is based on scientific and health knowledge. Along with its expert approach, it allows the company to create reliable and unique products. It manufactures one of the few drugs used internationally in the oncological immunotherapy of bladder cancer.
55GF Score

Get the complete analysis for WAR:SVE

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł3.00
Price
zł3.04
GF Value